|
|||||
|
|
| Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial | |
| 摘 要： | |
| 本文献已被 ScienceDirect 等数据库收录！ | |
|
||||||||
|
||||||||
|
||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |